Show source-provided references
1. Cotinus coggygria Scop.: An overview of its chemical constituents, pharmacological and toxicological potential
10.1016/j.sjbs.2015.05.012 ↗2. Antal, D.S., Ardelean, F., Jijie, R., Pinzaru, I., Soica, C., and Dehelean, C. (2021). Integrating ethnobotany, phytochemistry, and pharmacology of Cotinus coggygria and Toxicodendron vernicifluum: What predictions can be made for the European smoketree?. Front. Pharmacol., 12.
10.3389/fphar.2021.662852 ↗3. Ciocan, A.-G., Tecuceanu, V., Enache-Preoteasa, C., Mitoi, E.M., Helepciuc, F.E., Vassu Dimov, T., Simon-Gruita, A., and Cogălniceanu, G.C. (2023). Phenological and environmental factors’ impact on secondary metabolites in medicinal plant Cotinus coggygria Scop. Plants, 12.
10.3390/plants12091762 ↗4. Isolation and characterization of natural inhibitors of post-proline specific peptidases from the leaves of Cotinus coggygria Scop
10.1016/j.jep.2023.116508 ↗5. Sukhikh, S., Noskova, S., Pungin, A., Ivanova, S., Skrypnik, L., Chupakhin, E., and Babich, O. (2021). Study of the biologically active properties of medicinal plant Cotinus coggygria. Plants, 10.
10.3390/plants10061224 ↗6. Pašić, I., Novaković, M., Tešević, V., Milosavljević, S., Petrović, N., Stanojković, T., and Matić, I.Z. (2025). Exploring the anticancer potential of extracts and compounds from the heartwood of Cotinus coggygria Scop. wild growing in Serbia. BMC Complement. Med. Ther., 25.
10.1186/s12906-025-04768-3 ↗7. Wen, C., Dechsupa, N., Yu, Z., Zhang, X., Liang, S., Lei, X., Xu, T., Gao, X., Hu, Q., and Innuan, P. (2023). Pentagalloyl glucose: A review of anticancer properties, molecular targets, mechanisms of action, parmacokinetics, and safety profile. Molecules, 28.
10.3390/molecules28124856 ↗8. Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase
10.1016/j.neo.2014.11.002 ↗9. Cotinus coggygria non-volatile fraction affects the survival of human cultured cells
10. Kant, R., Yen, C.-H., Lu, C.-K., Lin, Y.-C., Li, J.-H., and Chen, Y.-M.A. (2016). Identification of 1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma. Int. J. Mol. Sci., 17.
10.3390/ijms17050669 ↗11. (2023, March 20). Dicrassin Ltd. and Bilkolechenie.bg. Available online: https://bilkolechenie.bg/.
16. A microgel electrophoresis technique for the direct quan-titation of DNA damage and repair in individual fibroblasts cultured on microscope slides
10.1016/0165-1161(91)90008-V ↗21. (2022, November 10). Protein Data Bank. RCSB PDB: The Research Collaboratory for Structural Bioinformatics Protein Data Bank. Available online: https://www.rcsb.org/.
22. (2022, April 11). BIOVIA Draw. Available online: https://biovia-draw-2021.software.informer.com/21.1/.
24. Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma
10.1002/cncr.35587 ↗26. Rundle, S., Bradbury, A., Drew, Y., and Curtin, N.J. (2017). Targeting the ATR-CHK1 axis in cancer therapy. Cancers, 9.
10.3390/cancers9050041 ↗27. (2025, April 30). BIOVIA Discovery Studio Visualizer. Available online: https://discover.3ds.com/discovery-studio-visualizer-download.
28. SwissDock 2024: Major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina
10.1093/nar/gkae300 ↗30. CB-Dock2: Improved protein–ligand blind docking by integrating cavity detection, docking and homologous template fitting
10.1093/nar/gkac394 ↗32. High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: Bound waters and natural ligand as guides for inhibitor design
10.1021/jm960402a ↗33. Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains
10.1021/cb4003283 ↗34. Mechanism of CDK activation revealed by the structure of a cyclin A–CDK2 complex
10.1038/376313a0 ↗35. Cyclin-dependent kinase (CDK) inhibitors: Structure–activity relationships and insights into the CDK2 selectivity of 6-substituted 2-arylaminopurines
10.1021/acs.jmedchem.6b01254 ↗38. (2022, November 15). Protein Data Bank. Available online: https://www.rcsb.org/structure/1ZYS.
41. Chemical profiling, antioxidant and antibacterial properties of Cotinus coggygria essential oil from Western Himalaya
42. Comprehensive analysis on Cotinus coggygria Scop. leaves: Phytochemical characterization, biological profile and docking studies
44. Brandl, N., Seitz, R., Sendtner, N., Müller, M., and Gülow, K. (2025). Living on the Edge: ROS Homeostasis in Cancer Cells and Its Potential as a Therapeutic Target. Antioxidants, 14.
10.3390/antiox14081002 ↗45. Penta-1,2,3,4,6-O-galloyl-β-D-glucose induces senescence-like terminal S-phase arrest in human hepatoma and breast cancer cells
10.1002/mc.20743 ↗46. Fagbohun, O.F., Gillies, C.R., Murphy, K.P.J., and Rupasinghe, H.P.V. (2023). Role of Antioxidant Vitamins and Other Micronutrients on Regulations of Specific Genes and Signaling Pathways in the Prevention and Treatment of Cancer. Int. J. Mol. Sci., 24.
10.3390/ijms24076092 ↗47. Distribution of prolyl oligopeptidase in human peripheral tissues and in ovarian and colorectal tumors
10.1369/0022155412453051 ↗50. Therapeutic Effect of Prolyl Endopeptidase Inhibitor in High-fat Diet-induced Metabolic Dysfunction-associated Fatty Liver Disease
51. Cotinus coggygria Scop. induces cell cycle arrest, apoptosis, genotoxic effects, thermodynamic and epigenetic events in MCF7 breast cancer cells
10.1515/znc-2020-0087 ↗53. Pollio, A., Zarrelli, A., Romanucci, V., Di Mauro, A., Barra, F., Pinto, G., Crescenzi, E., Roscetto, E., and Palumbo, G. (2016). Polyphenolic Profile and Targeted Bioactivity of Methanolic Extracts from Mediterranean Ethnomedicinal Plants on Human Cancer Cell Lines. Molecules, 21.
10.3390/molecules21040395 ↗54. Wendlocha, D., Kubina, R., Krzykawski, K., and Mielczarek-Palacz, A. (2024). Selected Flavonols Targeting Cell Death Pathways in Cancer Therapy: The Latest Achievements in Research on Apoptosis, Autophagy, Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis. Nutrients, 16.
10.3390/nu16081201 ↗57. Antiproliferative properties against human breast, cervical and ovarian cancer cell lines, and antioxidant capacity of leaf aqueous-ethanolic extract from Cotinus coggygria Scop
64. Molecular docking a gateway to rational drug design and precision medicine
65. Induction of G1 Phase Arrest in MCF Human Breast Cancer Cells by Pentagalloylglucose through the Down-Regulation of CDK4 and CDK2 Activities and Up-Regulation of the CDK Inhibitors p27Kip and p21Cip
10.1016/S0006-2952(03)00156-4 ↗66. Penta-O-galloyl-β-D-glucose Induces G1 Arrest and DNA Replicative S-Phase Arrest Independently of P21 Cyclin-Dependent Kinase Inhibitor 1A, P27 Cyclin-Dependent Kinase Inhibitor 1B and P53 in Human Breast Cancer Cells and Is Orally Active against Triple-Negative Xenograft Growth
10.1186/bcr2634 ↗